Talk:Cholesterylester transfer protein

From Wikipedia, the free encyclopedia
Jump to: navigation, search
WikiProject Physiology (Rated Start-class, Mid-importance)
WikiProject icon This article is within the scope of WikiProject Physiology, a collaborative effort to improve the coverage of Physiology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
Start-Class article Start  This article has been rated as Start-Class on the quality scale.
 Mid  This article has been rated as Mid-importance on the importance scale.
Taskforce icon
This article has been classified as relating to blood.
WikiProject Molecular and Cell Biology (Rated Start-class, Low-importance)
WikiProject icon This article is within the scope of the WikiProject Molecular and Cell Biology. To participate, visit the WikiProject for more information.
Start-Class article Start  This article has been rated as Start-Class on the project's quality scale.
 Low  This article has been rated as Low-importance on the project's importance scale.


Many professional publications, including the references, refer to this protein as "cholesteryl ester transfer protein", with a space between cholesteryl and ester. Chemically, I suspect it should be one word. Anyone an idea about this? JFW | T@lk 09:46, 20 November 2005 (UTC)

Should we carry on fiddling with HDL[edit]

PMID 17699012 doesn't think so. JFW | T@lk 12:57, 4 November 2007 (UTC)

Homoexchange purpose?[edit]

I find the intro paragraph confusing and don't see explanation in the body of text:

  • What main purpose does CETP serve?
  • What good (to the body) is a homoexchange ("trading a triglyceride for a triglyceride or a cholesteryl ester for a cholesteryl ester") between HDL and VLDL?
  • By the description here, both VLDL and HDL are largely unchanged after CETP does its thing. So how does inhibiting CETP change the level of either?
  • According to the title of the first ref (Zhong S) increasing CETP function increased HDL. So how does torcetrapib lowering CETP increase HDL?

—(updated) David.Throop (talk) 03:58, 18 November 2007 (UTC)

We need someone who knows the topic to look at the 20 Jan 2012 change. It has to be wrong or the 'or' clause is redundant. But I don't know whether to revert the change or to make it 'trading a triglyceride for a cholesteryl ester or a cholesteryl ester for a triglyceride' I lean towards revert, but.... Thanks — Preceding unsigned comment added by (talk) 00:34, 25 January 2012 (UTC)

Useful source[edit]

doi:10.1194/jlr.R400007-JLR200 outlines CETP vs atherosclerosis. This predates the torcetratib debacle. JFW | T@lk 23:57, 2 April 2008 (UTC)

Long Life[edit]

There are some rather exciting studies which have CETP linked to long life, good heart health, a reduced risk of cognitive decline with age and a smaller chance of developing Alzheimer's disease. Very cool, if true! It is mentioned in an article in reuters: I'd like to see this mentioned (preferably by someone who is very familiar with this sort of science). Gingermint (talk) 19:11, 27 April 2010 (UTC)